Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness product to enable wearers to get an electrocardiogram (ECG) from their wristwatch. The device monitors the user’s heart rate and rhythm, sending notifications if abnormal findings are detected.

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist.

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation (AF) and speed interventions like anticoagulation. Without anticoagulation, a person with AF may be up to five times more likely to have an ischemic stroke than someone without AF.[1] 

Advancements in Wearable ECG Technology


Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage, age, genetics and medications.



Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years.



Holter monitors are firmly ensconced as the standard device for remote cardiac monitoring. But does that make them the best option?



Sudden cardiac arrest is a complex and challenging medical emergency because it can occur anywhere at any time and is likely to be fatal unless care teams can swiftly and accurately intervene.


It recently was announced that two leaders in cardiovascular disease science, research and education — the American Heart Association (AHA) and the Cardiovascular Research Foundation (CRF) — are joining forces, which will help strengthen and expand educational opportunities in cardiovascular disease and interventional therapi

Subscribe Now